Concise review: how do red blood cells born, live, and die? J.L. Vives CorronsL. Berga CasafontE. Feliu Frasnedo Review Article 03 August 2021 Pages: 2425 - 2433
Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia Wenrui YangXin ZhaoFengkui Zhang Original Article 16 July 2021 Pages: 2435 - 2441
Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study Lalita NorasetthadaSomchai Wongkhanteefor the Thai Aplastic Anemia Study Group Original Article Open access 16 July 2021 Pages: 2443 - 2452
SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients Shuwen WangXiaoyu ZhangXiang Hu Original Article 16 July 2021 Pages: 2453 - 2462
Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype Negin ShokrgozarMehran KarimiNargess Arandi Original Article 29 July 2021 Pages: 2463 - 2469
Digital thermography and vascular involvement in β-thalassemia intermedia Farah AbdulhaiMiran A. JaffaMarwan M. Refaat Original Article 08 July 2021 Pages: 2471 - 2477
Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia Ryujiro HaraMakoto OnizukaKiyoshi Ando Original Article 11 July 2021 Pages: 2479 - 2486
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL Nupur DasRitu GuptaLalit Kumar Original Article 08 July 2021 Pages: 2487 - 2500
Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985–2017) Neda AlrawashdhJoann SweasyIvo Abraham Original Article 19 July 2021 Pages: 2501 - 2512
Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database Radowan ElnairMoataz EllithiRobert G. Bociek Original Article 19 July 2021 Pages: 2513 - 2519
N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institution Victor H. Jimenez-ZepedaHolly LeeNizar J. Bahlis Original Article 21 July 2021 Pages: 2521 - 2527
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study Won Seog KimYasuhiro OkiHelen E. Heslop Original Article 24 July 2021 Pages: 2529 - 2539
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience Marta KrejciLudek PourZdenek Kral Original Article 26 July 2021 Pages: 2541 - 2546
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi Armando SantoroRita MazzaFrancesco Merli Original Article 30 July 2021 Pages: 2547 - 2556
Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment Jun KongYa-zhen QinHao Jiang Original Article 19 July 2021 Pages: 2557 - 2566
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms Hyoung Soo ChoiJunshik HongSoo-Mee Bang Original Article 30 July 2021 Pages: 2567 - 2574
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients Judith StrapatsasElena Calina BarbulescuUlrich Germing Original Article Open access 29 July 2021 Pages: 2575 - 2584
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion Neal ShahKevin RakszawskiKentaro Minagawa Original Article 29 July 2021 Pages: 2585 - 2592
Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia Ruihua MiLin ChenXudong Wei Original Article Open access 27 July 2021 Pages: 2593 - 2601
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy Olivier BalloFagr EladlyChristian H. Brandts Original Article Open access 25 July 2021 Pages: 2603 - 2611
Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan Kensuke MatsudaTaisuke JoMineo Kurokawa Original Article 26 July 2021 Pages: 2613 - 2619
Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study Jamshid MotaeiMohammad Amin KerachianMarjan Yaghmaie Original Article 11 July 2021 Pages: 2621 - 2631
Sustained remission of giant pancreatic plasmacytoma with daratumumab Satoshi IchikawaEijiro FurukawaHideo Harigae Letter to the Editor 18 June 2020 Pages: 2633 - 2634
A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type Mathias T. RosenfeldtElena M. HartmannIoannis Anagnostopoulos Letter to the Editor Open access 19 July 2020 Pages: 2635 - 2637
Effects of ruxolitinib on secondary myelofibrosis following chronic neutrophilic leukemia with the CSF3R T618I mutation Yuichi IkedaJun YamanouchiKatsuto Takenaka Letter to the Editor 16 July 2020 Pages: 2639 - 2641
A novel mutation in the JAK2 gene (R588S) in a Chinese patient with erythrocytosis Xiu-Peng YeJing WangShen Bao Letter to the Editor 31 July 2020 Pages: 2643 - 2645
HHV-8 negative PEL-like lymphoma follicular helper T type in a non-HIV infected elderly Keisuke KidoguchiMasumi UchinoKoichi Ohshima Letter to the Editor 17 August 2020 Pages: 2647 - 2648
Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver Andrea MarraGiovanni MartinoStefano Ascani Letter to the Editor 28 August 2020 Pages: 2649 - 2651
CD30 expression: a diagnostic pitfall for primary cutaneous gamma delta T cell lymphoma Karen H. K. TangRex Au-YeungYok-lam Kwong Letter to the Editor 28 August 2020 Pages: 2653 - 2657
High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 Luca RoncatiGiuliano BergonziniStefania Corrado Letter to the Editor 28 August 2020 Pages: 2659 - 2660
Persistent pseudo-Pelger-Huët anomaly Süreyya SavaşanSteven BuckJanet Poulik Letter to the Editor 29 August 2020 Pages: 2661 - 2663
A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis Satoshi IchikawaTohru FujiwaraHideo Harigae Letter to the Editor 31 August 2020 Pages: 2665 - 2668